{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:03:45Z","timestamp":1768975425027,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD097775"],"award-info":[{"award-number":["R01HD097775"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010573","name":"Center for Clinical and Translational Science, University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11095-025-03879-3","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T15:54:55Z","timestamp":1749138895000},"page":"2329-2338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PEGylation of Propofol Reduces Its Adsorption to Extracorporeal Membrane Oxygenator (ECMO) Components"],"prefix":"10.1007","volume":"42","author":[{"given":"Benedetta","family":"Campara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitish","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"De Nadai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata","family":"Yellepeddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Watt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Pasut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Ghandehari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"issue":"1","key":"3879_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.suc.2021.09.001","volume":"102","author":"WC Wrisinger","year":"2022","unstructured":"Wrisinger WC, Thompson SL. Basics of extracorporeal membrane oxygenation. Surg Clin North Am. 2022;102(1):23\u201335.","journal-title":"Surg Clin North Am"},{"issue":"7","key":"3879_CR2","first-page":"E166","volume":"7","author":"G Makdisi","year":"2015","unstructured":"Makdisi G, Wang IW. Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis. 2015;7(7):E166\u201376.","journal-title":"J Thorac Dis"},{"issue":"5","key":"3879_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2165\/00003088-200342050-00001","volume":"42","author":"ML Buck","year":"2003","unstructured":"Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet. 2003;42(5):403\u201317.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"3879_CR4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1097\/MAT.0000000000001758","volume":"68","author":"J Crow","year":"2022","unstructured":"Crow J, Lindsley J, Cho SM, Wang J, Lantry JH, Kim BS, et al. Analgosedation in critically ill adults receiving extracorporeal membrane oxygenation support. ASAIO J. 2022;68(12):1419\u201327.","journal-title":"ASAIO J"},{"issue":"2","key":"3879_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MAT.0000000000002128","volume":"70","author":"JE Tonna","year":"2024","unstructured":"Tonna JE, Boonstra PS, MacLaren G, Paden M, Brodie D, Anders M, et al. Extracorporeal life support organization registry international report 2022: 100,000 Survivors. ASAIO J. 2024;70(2):131\u201343.","journal-title":"ASAIO J"},{"issue":"10307","key":"3879_CR6","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0140-6736(21)01960-7","volume":"398","author":"RP Barbaro","year":"2021","unstructured":"Barbaro RP, MacLaren G, Boonstra PS, Combes A, Agerstrand C, Annich G, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet. 2021;398(10307):1230\u20138.","journal-title":"Lancet"},{"issue":"8","key":"3879_CR7","first-page":"e43590","volume":"15","author":"RR Sanivarapu","year":"2023","unstructured":"Sanivarapu RR, Osman U, Latha KA. A systematic review of mortality rates among adult acute respiratory distress syndrome patients undergoing extracorporeal membrane oxygenation therapy. Cureus. 2023;15(8):e43590.","journal-title":"Cureus"},{"issue":"5","key":"3879_CR8","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/jcm11051224","volume":"11","author":"B Treml","year":"2022","unstructured":"Treml B, Breitkopf R, Bukumiri\u0107 Z, Bachler M, Boesch J, Rajsic S. ECMO predictors of mortality: A 10-year referral centre experience. J Clin Med. 2022;11(5):1224.","journal-title":"J Clin Med."},{"issue":"6","key":"3879_CR9","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00134-007-0606-2","volume":"33","author":"NM Mehta","year":"2007","unstructured":"Mehta NM, Halwick DR, Dodson BL, Thompson JE, Arnold JH. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med. 2007;33(6):1018\u201324.","journal-title":"Intensive Care Med"},{"issue":"12","key":"3879_CR10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00134-010-2041-z","volume":"36","author":"ED Wildschut","year":"2010","unstructured":"Wildschut ED, Ahsman MJ, Allegaert K, Mathot RA, Tibboel D. Determinants of drug absorption in different ECMO circuits. Intensive Care Med. 2010;36(12):2109\u201316.","journal-title":"Intensive Care Med"},{"issue":"3","key":"3879_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ejpb.2006.06.005","volume":"64","author":"JJ Palmgr\u00e9n","year":"2006","unstructured":"Palmgr\u00e9n JJ, M\u00f6nkk\u00f6nen J, Korjamo T, Hassinen A, Auriola S. Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions. Eur J Pharm Biopharm. 2006;64(3):369\u201378.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"3879_CR12","first-page":"288","volume":"19","author":"AA Harthan","year":"2014","unstructured":"Harthan AA, Buckley KW, Heger ML, Fortuna RS, Mays K. Medication adsorption into contemporary extracorporeal membrane oxygenator circuits. J Pediatr Pharmacol Ther. 2014;19(4):288\u201395.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"3879_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1051\/ject\/200739234","volume":"39","author":"TJ Preston","year":"2007","unstructured":"Preston TJ, Hodge AB, Riley JB, Leib-Sargel C, Nicol KK. In vitro drug adsorption and plasma free hemoglobin levels associated with hollow fiber oxygenators in the extracorporeal life support (ECLS) circuit. J Extra Corpor Technol. 2007;39(4):234\u20137.","journal-title":"J Extra Corpor Technol"},{"issue":"3","key":"3879_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1051\/ject\/201042199","volume":"42","author":"TJ Preston","year":"2010","unstructured":"Preston TJ, Ratliff TM, Gomez D, Olshove VE, Nicol KK, Sargel CL, et al. Modified surface coatings and their effect on drug adsorption within the extracorporeal life support circuit. J Extra Corpor Technol. 2010;42(3):199\u2013202.","journal-title":"J Extra Corpor Technol"},{"issue":"4","key":"3879_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1051\/ject\/2023036","volume":"55","author":"N Khurana","year":"2023","unstructured":"Khurana N, S\u00fcnner T, Hubbard O, Imburgia CE, Yellepeddi V, Ghandehari H, et al. Direct and continuous dosing of propofol can saturate Ex vivo ECMO circuit to improve propofol recovery. J Extra Corpor Technol. 2023;55(4):194\u20136.","journal-title":"J Extra Corpor Technol"},{"issue":"9","key":"3879_CR16","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.clinthera.2016.07.169","volume":"38","author":"J Sherwin","year":"2016","unstructured":"Sherwin J, Heath T, Watt K. Pharmacokinetics and Dosing of Anti-infective drugs in patients on extracorporeal membrane oxygenation: A review of the current literature. Clin Ther. 2016;38(9):1976\u201394.","journal-title":"Clin Ther"},{"issue":"Suppl 5","key":"3879_CR17","doi-asserted-by":"publisher","first-page":"S642","DOI":"10.21037\/jtd.2017.11.02","volume":"10","author":"M Di Nardo","year":"2018","unstructured":"Di Nardo M, Wildschut ED. Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics. J Thorac Dis. 2018;10(Suppl 5):S642\u201352.","journal-title":"J Thorac Dis"},{"issue":"4","key":"3879_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s42114-021-00244-x","volume":"4","author":"T He","year":"2021","unstructured":"He T, He J, Wang Z, Cui Z. Modification strategies to improve the membrane hemocompatibility in extracorporeal membrane oxygenator (ECMO). Adv Compos Hybrid Mater. 2021;4(4):847\u201364.","journal-title":"Adv Compos Hybrid Mater"},{"issue":"8","key":"3879_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/membranes11080617","volume":"11","author":"A Willers","year":"2021","unstructured":"Willers A, Arens J, Mariani S, Pels H, Maessen JG, Hackeng TM, et al. New trends, advantages and disadvantages in anticoagulation and coating methods used in extracorporeal life support devices. Membranes (Basel). 2021;11(8):617.","journal-title":"Membranes (Basel)."},{"issue":"4","key":"3879_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1208\/s12248-023-00817-2","volume":"25","author":"N Khurana","year":"2023","unstructured":"Khurana N, S\u00fcnner T, Hubbard O, Imburgia C, Stoddard GJ, Yellepeddi V, et al. Micellar encapsulation of propofol reduces its adsorption on Extracorporeal Membrane Oxygenator (ECMO) circuit. AAPS J. 2023;25(4):52.","journal-title":"AAPS J"},{"issue":"Suppl 4","key":"3879_CR21","doi-asserted-by":"publisher","first-page":"S400","DOI":"10.1007\/PL00003783","volume":"26","author":"KA Thompson","year":"2000","unstructured":"Thompson KA, Goodale DB. The recent development of propofol (DIPRIVAN). Intensive Care Med. 2000;26(Suppl 4):S400\u20134.","journal-title":"Intensive Care Med"},{"key":"3879_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13054-015-0772-5","volume":"19","author":"F Lemaitre","year":"2015","unstructured":"Lemaitre F, Hasni N, Leprince P, Corvol E, Belhabib G, Fill\u00e2tre P, et al. Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood. Crit Care. 2015;19:40.","journal-title":"Crit Care"},{"issue":"7","key":"3879_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/BF03009997","volume":"41","author":"M Hynynen","year":"1994","unstructured":"Hynynen M, Hammar\u00e9n E, Rosenberg PH. Propofol sequestration within the extracorporeal circuit. Can J Anaesth. 1994;41(7):583\u20138.","journal-title":"Can J Anaesth"},{"issue":"1","key":"3879_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/026765910001500104","volume":"15","author":"H Mulla","year":"2000","unstructured":"Mulla H, Lawson G, von Anrep C, Burke MD, Upton DU, Firmin RK, et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion. 2000;15(1):21\u20136.","journal-title":"Perfusion"},{"issue":"1","key":"3879_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13054-017-1644-y","volume":"21","author":"AL Dzierba","year":"2017","unstructured":"Dzierba AL, Abrams D, Brodie D. Medicating patients during extracorporeal membrane oxygenation: the evidence is building. Crit Care. 2017;21(1):66.","journal-title":"Crit Care"},{"issue":"3","key":"3879_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1689","volume":"13","author":"A Grigoletto","year":"2021","unstructured":"Grigoletto A, Tedeschini T, Canato E, Pasut G. The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13(3): e1689.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"21","key":"3879_CR27","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","volume":"10","author":"FM Veronese","year":"2005","unstructured":"Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today. 2005;10(21):1451\u20138.","journal-title":"Drug Discov Today"},{"issue":"3","key":"3879_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003;2(3):214\u201321.","journal-title":"Nat Rev Drug Discov"},{"issue":"36","key":"3879_CR29","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1002\/anie.200902672","volume":"49","author":"K Knop","year":"2010","unstructured":"Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl. 2010;49(36):6288\u2013308.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3879_CR30","unstructured":"Propofol Injectable Emulsion , USP, (2012) 63323."},{"key":"3879_CR31","doi-asserted-by":"crossref","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331","DOI":"10.4103\/0976-0105.177703"},{"issue":"1","key":"3879_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ibra.12030","volume":"8","author":"D Luo","year":"2022","unstructured":"Luo D, Chen SY, Zhang Y. Effects of different injection methods of propofol anesthesia on the behavior and electroencephalography recording in mice. Ibrain. 2022;8(1):109\u201316.","journal-title":"Ibrain"},{"issue":"22","key":"3879_CR33","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1016\/j.bmcl.2018.10.009","volume":"28","author":"T Deng","year":"2018","unstructured":"Deng T, Mao X, Li Y, Bo S, Yang Z, Jiang ZX. Monodisperse oligoethylene glycols modified Propofol prodrugs. Bioorg Med Chem Lett. 2018;28(22):3502\u20135.","journal-title":"Bioorg Med Chem Lett"},{"issue":"Suppl 5","key":"3879_CR34","doi-asserted-by":"publisher","first-page":"S629","DOI":"10.21037\/jtd.2017.09.154","volume":"10","author":"V Cheng","year":"2018","unstructured":"Cheng V, Abdul-Aziz MH, Roberts JA, Shekar K. Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. J Thorac Dis. 2018;10(Suppl 5):S629\u201341.","journal-title":"J Thorac Dis"},{"key":"3879_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114261","volume":"198","author":"N Khurana","year":"2024","unstructured":"Khurana N, Watkins K, Ghatak D, Staples J, Hubbard O, Yellepeddi V, et al. Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model. Eur J Pharm Biopharm. 2024;198: 114261.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3879_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8(1):102.","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"3879_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i1.10","volume":"19","author":"AV Kabanov","year":"2002","unstructured":"Kabanov AV, Alakhov VY. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst. 2002;19(1):1\u201372.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"3879_CR38","doi-asserted-by":"crossref","unstructured":"Shi Y, Lammers T, Storm G, Hennink WE. Physico-chemical strategies to enhance stability and drug retention of polymeric micelles for tumor-targeted drug delivery. Macromol Biosci. 2017;17(1):1\u201311.","DOI":"10.1002\/mabi.201600160"},{"key":"3879_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-1-4615-0123-7_15","volume":"513","author":"WM Pardridge","year":"2002","unstructured":"Pardridge WM. Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins. Adv Exp Med Biol. 2002;513:397\u2013430.","journal-title":"Adv Exp Med Biol"},{"issue":"25","key":"3879_CR40","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1310246","volume":"370","author":"WD Chey","year":"2014","unstructured":"Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med. 2014;370(25):2387\u201396.","journal-title":"N Engl J Med"},{"issue":"5","key":"3879_CR41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1177\/1756283X16648869","volume":"9","author":"W Leppert","year":"2016","unstructured":"Leppert W, Woron J. The role of naloxegol in the management of opioid-induced bowel dysfunction. Therap Adv Gastroenterol. 2016;9(5):736\u201346.","journal-title":"Therap Adv Gastroenterol"},{"issue":"10","key":"3879_CR42","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1021\/bm100561v","volume":"11","author":"F Li","year":"2010","unstructured":"Li F, Danquah M, Mahato RI. Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery. Biomacromol. 2010;11(10):2610\u201320.","journal-title":"Biomacromol"},{"key":"3879_CR43","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3389\/fphar.2019.00808","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, Zhang T, Liu Q, He J. PEG-derivatized dual-functional nanomicelles for improved cancer therapy. Front Pharmacol. 2019;10:808.","journal-title":"Front Pharmacol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03879-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03879-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03879-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:50:40Z","timestamp":1768927840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03879-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3879"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03879-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests that could have influenced the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}